Results
1 -
10 of
70Effects of Cholesterol Ester Transfer Protein Inhibition on HDL Metabolism, High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease Lipid-modifying agents under development, Comprehensive lipid testing and management Emerging Small Molecule Drugs, High Density Lipoproteins Statins and CETP Inhibitors: Anacetrapib and Evacetrapib: The Last Hope?, Combination Therapy In Dyslipidemia Phase III Trial of Dalcetrapib, Pharmaceutical Medicine Tangier Disease, American Journal of Cardiovascular Drugs Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects, Clinical Drug Investigation Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol, Current Atherosclerosis Reports